Juliane Mietz

This study establishes an immunocompetent humanized tumor model and identifies exhausted-like CD8+ T cells with antitumor activity in vivo.

This study develops CAR T cells targeting a specific mutation in CLL to selectively kill cancer cells while sparing healthy B cells.